Endogenous cannabinoids as an aversive or counter-rewarding system in the rat

Neuroscience Letters

Volumn 223, Issue 2, 1997, Pages 125-128

  Sañudo Peña, M Clara ^a   Tsou, Kang ^a   Delay, Eugene R ^a   Hohman, Andrea G ^a   Force, Michelle ^a   Walker, J Michael ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

9 tetrahydrocannabinol; aversion; cannabinoid; marijuana; place preference; reward; SR141761A

Indexed keywords

CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; RIMONABANT; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVERSIVE BEHAVIOR; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD;

ANIMALS; AVOIDANCE LEARNING; CANNABINOIDS; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; REWARD; TETRAHYDROCANNABINOL;

EID: 0342437104     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)13424-3     Document Type: Article

References (29)

1. Aceto, M., Scates, S., Lowe, J. and Martin, B., Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist SR141716A, Eur. J. Pharmacol., 282 (1995) R1-R2.
2. Bozarth, M.A., Methods of Assessing the Reinforcing Properties of Abused Drugs, Springer-Verlag, New York, 1987.
3. Corcoran, M.E. and Amit, Z., Reluctance of rats to drink hashish suspensions: free-choice and forced consumption, and the effects of hypothalamic stimulation, Psychopharmacologia, 35 (1974) 129-147.
4. Fanselow, M.S. and Kim, J.J., The benzodiazepine inverse agonist DMCM as an unconditional stimulus for fear-induced analgesia: implications for the role of GABAA receptors in fear-related behavior, Behav. Neurosci., 106 (1992) 336-344.
5. 9-tetrahydrocannabinol, Psychopharmacology, 96 (1988) 142-144.
6. 9-tetrahydrocannabinol in rhesus monkeys, Psychopharmacologia, 37 (1974) 23-29.
7. Heilig, M., Koob, G.F., Ekman, R. and Britton, K.T., Corticotropin-releasing factor and neuropeptide Y: role in emotional integration, Trends Neurosci., 17 (1994) 80-85.
8. Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de Costa, B.R. and Rice, K.C., Characterization and localization of cannabinoid receptor in rat brain: a quantitative in vitro autoradiographic study, J. Neurosci., 11 (1991) 563-583.
9. Herkenham, M., Cannabinoid receptor localization in brain: relationship to motor and reward systems, Ann. N. Y. Acad. Sci., 654 (1992) 19-32.
10. 9-Tetrahydrocannabinol and the synthetic cannabinoid CP-55,940 induce expression of c-Fos mRNA in stress-responsive nuclei of rat brain, Soc. Neurosci. Abstr., 20 (1994) 1676.
11. Hollister, L.E., Health aspects of cannabis, Pharmacol. Rev., 38 (1986) 1-20.
12. Klüver, H. and Bucy, P.C., Preliminary analysis of functions of the temporal lobes in monkeys, Arch. Neurol. Psychiat., 42 (1939) 979-1000.
13. Laszlo, J., Lucas, V.S., Hanson, D.C., Cronin, C.M. and Sallan, S.E., Levonantradol for chemotherapy-induced emesis: phase I-II oral administration, J. Clin. Pharmacol., 21 (1981) 51S-56S.
14. Leite, J.R. and Carlini, E.A., Failure to obtain 'cannabis-directed behavior' and abstinence syndrome in rats chronically treated with cannabis sativa extracts, Psychopharmacologia, 36 (1974) 133-145.
15. 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward, Life Sci., 56 (1995) 2073-2080.
16. Mailleux, P. and Vanderhaeghen, J.J., Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry, Neuroscience, 48 (1992) 655-688.
17. McGregor, I.S., Issakidis, C.N. and Prior, G., Aversive effects of the synthetic cannabinoid CP 55,940 in rats, Pharmacol. Biochem. Behav., 53 (1996) 657-664.
18. Mechoulam, R., Shani, A., Edery, H. and Grunfeld, Y., Chemical basis of hashish activity, Science, 169 (1970) 611-612.
19. Noyes, J.R., Brunk, S.F., Avery, D.H. and Canter, A., The analgesic properties of delta-9-tetrahydrocannabinol and codeine, Clin. Pharmacol. Ther., 18 (1975) 84-89.
20. Onaivi, E.S., Green, M.R. and Martin, B.R., Pharmacological characterization of cannabinoids in the elevated plus maze, J. Pharmacol. Exp. Ther., 253 (1990) 1002-1009.
21. Olds, M.E. and Milner, P., Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain, J. Comp. Physiol. Psychol., 47 (1954) 419-427.
22. Parker, L.A. and Gillies, T., THC-induced place and taste aversions in Lewis and Sprague-Dawley rats, Behav. Neurosci., 109 (1995) 71-78.
23. Raft, D., Gregg, J., Ghia, J. and Harris, L., Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlate of the analgesic response, Clin. Pharmacol. Ther., 21 (1977) 26-33.
24. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrara, P., Soubrie, P., Breliere, J.C. and LeFur, G., SR141716A, a potent and selective antagonist of the brain cannabinoid receptor, FEBS Lett., 350 (1994) 240-244.
25. Rinaldi-Carmona, M., Calandra, B., Shire, D., Bouaboula, M., Oustric, D., Barth, F., Casellas, P., Ferrara, P. and LeFur, G., Characterization of two cloned human CB1 cannabinoid receptor isoforms, J. Pharmacol. Exp. Ther., 278 (1996) 871-878.
26. Stark, P. and Dews, P.B., Cannabinoids. I. Behavioral effects, J. Pharmacol. Exp. Ther., 214 (1980) 124-130.
27. 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist, Eur. J. Pharmacol., 280 (1995) R13-R15.
28. Tsou, K., Brown, S., Mackie, K. and Walker, J.M., Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system, J. Neurosci., (1997) submitted.
29. Wise, R.A. and Rompre, P.P., Brain dopamine and reward, Annu. Rev. Psychol., 40 (1989) 191-225.